» Articles » PMID: 31681468

Determination of Variability Due to Biological and Technical Variation in Urinary Extracellular Vesicles As a Crucial Step in Biomarker Discovery Studies

Overview
Publisher Wiley
Date 2019 Nov 5
PMID 31681468
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Urinary extracellular vesicles (EVs) are an attractive source of biomarkers for urological diseases. A crucial step in biomarker discovery studies is the determination of the variation parameters to perform a sample size calculation. In this way, a biomarker discovery study with sufficient statistical power can be performed to obtain biologically significant biomarkers. Here, a variation study was performed on both the protein and lipid content of urinary EVs of healthy individuals, aged between 52 and 69 years. Ultrafiltration (UF) in combination with size exclusion chromatography (SEC) was used to isolate the EVs from urine. Different experimental variation set-ups were used in this variation study. The calculated standard deviations (SDs) of the 90% least variable peptides and lipids did not exceed 2 and 1.2, respectively. These parameters can be used in a sample size calculation for a well-designed biomarker discovery study at the cargo of EVs.

Citing Articles

Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes.

Khoo A, Govindarajan M, Qiu Z, Liu L, Ignatchenko V, Waas M Nat Commun. 2024; 15(1):5069.

PMID: 38871730 PMC: 11176296. DOI: 10.1038/s41467-024-49424-5.


Exploring the role of urinary extracellular vesicles in kidney physiology, aging, and disease progression.

Grange C, Dalmasso A, Cortez J, Spokeviciute B, Bussolati B Am J Physiol Cell Physiol. 2023; 325(6):C1439-C1450.

PMID: 37842748 PMC: 10861146. DOI: 10.1152/ajpcell.00349.2023.


A Robust and Clinically Applicable Sample Preparation Protocol for Urinary Extracellular Vesicle Isolation Suitable for Mass Spectrometry-Based Proteomics.

Erozenci L, Bijnsdorp I, Piersma S, Jimenez C Methods Mol Biol. 2023; 2718:235-251.

PMID: 37665463 DOI: 10.1007/978-1-0716-3457-8_13.


Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients.

Jordaens S, Oeyen E, Willems H, Ameye F, De Wachter S, Pauwels P Biomolecules. 2023; 13(6).

PMID: 37371512 PMC: 10296596. DOI: 10.3390/biom13060932.


A survey to evaluate parameters governing the selection and application of extracellular vesicle isolation methods.

Williams S, Jalal A, Lewis M, Davies O J Tissue Eng. 2023; 14:20417314231155114.

PMID: 36911574 PMC: 9996742. DOI: 10.1177/20417314231155114.


References
1.
Del Boccio P, Raimondo F, Pieragostino D, Morosi L, Cozzi G, Sacchetta P . A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes. Electrophoresis. 2012; 33(4):689-96. DOI: 10.1002/elps.201100375. View

2.
Oeyen E, Van Mol K, Baggerman G, Willems H, Boonen K, Rolfo C . Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine. J Extracell Vesicles. 2018; 7(1):1490143. PMC: 6032024. DOI: 10.1080/20013078.2018.1490143. View

3.
Matyash V, Liebisch G, Kurzchalia T, Shevchenko A, Schwudke D . Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res. 2008; 49(5):1137-46. PMC: 2311442. DOI: 10.1194/jlr.D700041-JLR200. View

4.
Maes E, Valkenborg D, Baggerman G, Willems H, Landuyt B, Schoofs L . Determination of variation parameters as a crucial step in designing TMT-based clinical proteomics experiments. PLoS One. 2015; 10(3):e0120115. PMC: 4361338. DOI: 10.1371/journal.pone.0120115. View

5.
Hoorn E, Pisitkun T, Zietse R, Gross P, Frokiaer J, Wang N . Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton). 2005; 10(3):283-90. DOI: 10.1111/j.1440-1797.2005.00387.x. View